Oxytocin in patients with borderline personality disorders or major depressive disorders [Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung].
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Borderline personality disorders
- Focus Therapeutic Use
Most Recent Events
- 10 Nov 2020 Biomarkers information updated
- 26 Apr 2012 Planned End Date added to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 25 Aug 2011 New source identified and integrated (German Clinical Trials Register; DRKS0000060).